Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant

Abstract

Although osteonecrosis of femoral head (ONF) is one of the serious complications in systemic lupus erythematosus (SLE) associated with corticosteroid therapy, there has been few trials of prevention of ONF described. We aimed to prevent ONF in steroid-treated SLE patients using anticoagulant, warfarin, conducting a multicenter prospective study. Sixty newly diagnosed SLE patients requiring 40 mg/day or more prednisolone were alternately assigned to either of two groups; a warfarin group and a control one. Warfarin (1 ∼ 5 mg/day) was started together with the beginning of steroid therapy and continued at least for three months. Patients were observed for the development of silent ONF by magnetic resonance imaging (MRI) and symptomatic ONF by plain radiography for over five years. The warfarin group consisted of 31 patients (62 hips) and the control one 29 patients (58 hips). Silent ONF developed in 13 hips (21%) and 19 hips (33%) in the warfarin group and the control group, respectively (P = 0.13). On the other hand, warfarin tended to prevent symptomatic ONF; only three hips of 62 (4.8%) in the warfarin group and eight hips of 58 (14%) in the control group (P = 0.08) developed silent ONF. It was also found that silent ONF developed, if it did, very early; within three months in 16 of 18 patients (89%). Among risk factors for silent ONF, steroid pulse therapy was most outstanding and it seemed to overcome the effect of warfarin. Taken together, for the time being, anticoagulant therapy, if not significantly sufficient, may be of use for the prevention of steroid-induced ONF in SLE. We consider that this study added to important evidence for the pathogenesis and prevention of ONF.

Keywords

osteonecrosis of femoral head SLE warfarin corticosteroid clinical trial

Get full access to this article

View all access options for this article.

References

Rascu A , Manger K , Kraetsch H-G , Kalden JR , Manger B.

Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?

Lupus 1996; 5: 323-327 .

Gladman DD , Urowitz MB , Chaudhry-Ahluwalia V , Hallet DC , Cook RJ. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus . J Rheumatol 2001; 28: 761-765 .

Mont MA , Glueck CJ , Pacheco IH , Wang P , Hungerford DS , Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus . J Rheumatol 1997; 24: 654-662 .

Mok CC , Lau CS , Wong RWS. Risk factors for avascular bone necrosis in systemic lupus erythematosus . Br J Rheumatol 1998; 37: 895-900 .

Assouline-Dayan Y , Chang C , Greenspan A , Shoenfeld Y , Gershwin ME. Pathogenesis and natural history of osteonecrosis . Sem Arthritis Rheum 2002; 32: 94-124 .

Nagasawa K , Ishii Y , Mayumi T et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haematostatic abnormalities . Ann Rheum Dis 1989; 48: 672-676 .

Cui Q , Wang GJ , Su CC , Balian G. Lovastatin prevents steroid induced adipogenesis and osteonecrosis . Clin Orthop Rel Res 1997; 344: 8-19 .

Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids . Clin Orthop Rel Res 2001; 386: 173-178 .

Tan EM , Cohen AS , Fries JS et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

10.

Nagasawa K , Tada Y , Koarada S et al. Very early development of steroid associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI . Lupus 2005; 14: 385-390 .

11.

Dubois EL , Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus . JAMA 1960; 174: 966-984 .

12.

Oinuma K , Harada Y , Nawata Y et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment . Ann Rheum Dis 2001; 60: 1145-1148 .

13.

Kalunian KC , Hahn BH , Bassett L. Magnetic resonance imaging identifies early femoral head ischemic necrosis in patients receiving systemic glucocorticoid therapy . J Rheumatol 1989; 16: 959-963 .

14.

Hauzeur J-P , Sintzoff JrS , Appelboom T , Maertelaer VD , Bentin J , Pasteels JL. Relationship between magnetic resonance imaging and histologic findings by bone biopsy in nontraumatic osteonecrosis of the femoral head . J Rheumatol 1992; 19: 385-392 .

15.

Nagasawa K , Tsukamoto H , Tada Y et al. Imaging study on the mode of development and changes in avascular necrosis of the femopral head in systemic lupus erythematosus: Long-term observations . Br J Rheumatol 1994; 33: 343-347 .

16.

Massardo E , Jacobelli S , Leissner M , Gonzales M , Villarroel L , Rivero S. High dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus . Lupus 1992; 1: 401-405 .